IE
ACIU icon

Israel Englander’s AC Immune ACIU Stock Holding History

Israel Englander’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-94,900
Closed -$274K – 5954
2025
Q3 		$274K Buy
+94,900
New +$214K ﹤0.01% 5378
2023
Q3 		– Sell
-100,000
Closed -$296K – 6057
2023
Q2 		$296K Buy
+100,000
New +$218K ﹤0.01% 4892
2020
Q4 		– Sell
-200,000
Closed -$976 – 5149
2020
Q3 		$976 Buy
+200,000
New +$1.44M ﹤0.01% 3151

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Israel Englander's ACIU Position: Q2 2026 in Review

Israel Englander reduced its AC Immune (ACIU) stake by 2.4% in Q2 2026, selling an estimated $52.5K and leaving 773,594 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3888.

Israel Englander first reported a position in ACIU in Q3 2016 and has held it in 26 quarters since. The position peaked at $3.63M in Q1 2020. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Israel Englander held 773,594 shares of AC Immune worth $1.84M as of Q2 2026.
  • Israel Englander sold 19,063 AC Immune shares in Q2 2026, an estimated $52.5K.
  • AC Immune made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3888 holding.
  • Israel Englander first reported a position in AC Immune in Q3 2016 and has held it in 26 quarters since.
  • Israel Englander's AC Immune position peaked at $3.63M in Q1 2020.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.